Showing results (1661-1670 of 5,060) with videos related to

Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|May 16, 2022
Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case seriesGiovanna S Manzano, Kathryn B Holroyd, Tamara Kaplan, et al.
Multiple Sclerosis and Related Disorders|May 16, 2022
The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosisStella A Glasmacher, Patrick Ka Kearns, Zackary Hassan, et al.
Multiple Sclerosis and Related Disorders|July 18, 2021
Vascular endothelial dysfunction associated with severity in multiple sclerosisKensuke Senzaki, Yoko Okada, Hirofumi Ochi, et al.
Multiple Sclerosis and Related Disorders|July 21, 2021
Review of Phase III Clinical Trials Outcomes in Patients with Secondary Progressive Multiple SclerosisMatthew McAdams, James M Stankiewicz, Howard L Weiner, et al.
Multiple Sclerosis and Related Disorders|July 21, 2021
A variant of uncertain significance in SDHAF1, the succinate dehydrogenase chaperone protein, in an adult patient with spastic paraparesis and leukoencephalopathyL Vlahovic, C B Lock, M H Han, et al.
Multiple Sclerosis and Related Disorders|May 24, 2022
A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacyMiranda Z Kozlicki, Brandon Markley, Nisha B Shah, et al.
Multiple Sclerosis and Related Disorders|May 25, 2022
The effect of cognitive performance on self-management behavior of multiple sclerosis patientsHüsnü Efendi, Aysun Ünal, Aylin Akçalı, et al.
Multiple Sclerosis and Related Disorders|July 23, 2021
Key points to keep in mind related to COVID-19 vaccines in people with multiple sclerosisLorna Galleguillos, Ricardo Alonso
Multiple Sclerosis and Related Disorders|May 21, 2022
Feedback from neurology residents and neuroimmunology fellows about the practical training in multiple sclerosisGuilherme Diogo Silva
Multiple Sclerosis and Related Disorders|May 9, 2022
miRNAs in multiple sclerosis: A clinical approachClaudia Minutti-Zanella, Lorena Bojalil-Álvarez, Elizabeth García-Villaseñor, et al.
Pageof 506